• Login
  • For Biosciences
  • For Providers
  • Who We Are
  • News
  • Contact
EMOL Health
  • Contact
  • Login
  • For Providers
  • For Biosciences
  • Who We Are
  • News
Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks

Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks

by EMOL Admin | Jun 12, 2023 | Technology

Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer that affects younger individuals and African Americans disproportionately. EMOL Health took part with researchers studying TNBC’s pathways and found that targeting certain genes (STAT3,...

Recent Posts

  • IASLC World Conference on Lung Cancer
  • EMOL Health and ALL4Cure
  • EMOL Health’s Real-World Data in Action
  • 2023 ASCO Quality Care Symposium
  • NCTA Announces 43 Oncology Practices As Inaugural Members

5158 Elmhurst Ave
Royal Oak MI 48073

Office: 248.434.1670

Fax: 248.928.7036

Privacy Policy

Copyright ©2024-2025 EMOL Health